Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nirosha Mahendraratnam Lederer"'
Autor:
Jennifer Graff, Nirosha Mahendraratnam Lederer, L. Orsini, Sebastian Schneeweiss, Gregory W. Daniel, Brigitta Monz, John Guerino, Shirley V. Wang, Richard J. Willke, Hans-Georg Eichler, Pall Jonsson, Marc L. Berger, Wim G. Goettsch, David Van Brunt, C. Daniel Mullins, William H. Crown
Publikováno v:
Pharmacoepidemiology and Drug Safety. 29:1504-1513
Real-world data (RWD) and the derivations of these data into real-world evidence (RWE) are rapidly expanding from informing healthcare decisions at the patient and health system level to influencing major health policy decisions, including regulatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::276ed98190b548d1f7a7ecbed8ecaf14
https://doi.org/10.1002/pds.5079
https://doi.org/10.1002/pds.5079
Autor:
Vishal Bhatnagar, Janice Kim, Abhilasha Nair, Bellinda L King-Kallimanis, Erica G. Horodniceanu, Paul G. Kluetz, Nirosha Mahendraratnam Lederer
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 24(9)
Objectives How frequently patient-reported outcome (PRO) data are collected in commercial cancer clinical trials after treatment discontinuation and the quality of that data are poorly understood. We reviewed treatment discontinuation follow-up PRO d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1e1b3b29f0a34ad801556c374c22e7b
https://pubmed.ncbi.nlm.nih.gov/34452710
https://pubmed.ncbi.nlm.nih.gov/34452710